LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...

The Spectra Optia Apheresis System (Terumo BCT) is an apheresis and cell collection platform which can be used in the treatment of sickle cell disease. The purpose of this evaluation is to assess the ...

Subscribe to our newsletter and stay updated on the latest developments and special offers!

Bermuda Hospitals Board has unveiled a new machine to vastly improve its service for sickle-cell patients. The Spectra Optia therapeutic apheresis machine, which extracts and filters blood, was bought ...

Kisumu — KISUMU, Kenya, Jan 26 -- Victoria Hospital in Kisumu, an annex of the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), has become the first public hospital in Kenya to acquire ...

Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths [1, 2] and taking more lives than cancer [3]. This is more than ...